SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-000207
Filing Date
2025-01-14
Accepted
2025-01-14 17:15:40
Documents
60
Period of Report
2024-11-30

Document Format Files

Seq Description Document Type Size
1 10-Q cydy-20241130x10q.htm   iXBRL 10-Q 1697951
2 EX-31.1 cydy-20241130xex31d1.htm EX-31.1 9187
3 EX-31.2 cydy-20241130xex31d2.htm EX-31.2 9332
4 EX-32 cydy-20241130xex32.htm EX-32 7654
  Complete submission text file 0001558370-25-000207.txt   6202963

Data Files

Seq Description Document Type Size
5 EX-101.SCH cydy-20241130.xsd EX-101.SCH 48826
6 EX-101.CAL cydy-20241130_cal.xml EX-101.CAL 46787
7 EX-101.DEF cydy-20241130_def.xml EX-101.DEF 159200
8 EX-101.LAB cydy-20241130_lab.xml EX-101.LAB 332228
9 EX-101.PRE cydy-20241130_pre.xml EX-101.PRE 273643
63 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20241130x10q_htm.xml XML 1017249
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 25530206
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)